1

MEDICAL PUBLICATION
CONFERENCES AND SEMINARS
MARKETING RESEARCH

  • Probiotic strains Lactobacillus acidophilus R0052 and Lactobacillus rhamnosus R0011 in the evolution of antibiotic-associated diarrhea in children with burn injury
en To content

Probiotic strains Lactobacillus acidophilus R0052 and Lactobacillus rhamnosus R0011 in the evolution of antibiotic-associated diarrhea in children with burn injury

SOVREMENNAYA PEDIATRIYA. 2015.2(66):102-104; doi 10.15574/SP.2015.66.102

Probiotic strains Lactobacillus acidophilus R0052 and Lactobacillus rhamnosus R0011 in the evolution of antibiotic-associated diarrhea in children with burn injury

Skripnikova Ya. S., Ivan'ko O. G., Patsera M. V., Ponomarenko E. V., Radutnaya E. A. 
Zaporizhzhya State Medical University, Ukraine

Objective. To examine the incidence, characteristics of the course and possible prevention of antibiotic-associated diarrhea (AAD) in burn patients.

Patients and methods. A total of 452 children with burn injuries who had received antibiotics were under observation for the period from 2010 to 2014yy. in the regional burns unit department of Zaporizhzhya.

Results. In the setting of the treatment of burn injuries the AAD of varying severity was found in 8.6–24% of children. In 76% of children AAD accompanied by the release of pathogenic toxins Clostridium difficile. The methods for prevention of AAD were developed first of all for the aim of preventive application of oral probiotic containing probiotic strains Lactobacillus acidophilus R0052 and Lactobacillus rhamnosusR0011 from early hospitalization as part of the preparation «Latsidofil®» in the age dosages.

Conclusions. Antibiotic diarrhea is a significant problem of patients of burn department. The use of probiotic preparation «Latsidofil®» in the complex treatment of burn injury decreased the incidence of AAD in three times and reduced the severity of its symptoms. Key words: children, burn injury, antibiotic therapy, antibiotic-associated diarrhea, probiotic strains Lactobacillua cidophilus R0052 and Lactobacillus rhamnosus R0011.

REFERENCES

1. Крутиков МГ, Бобровников АЭ. 2000. Антибиотикопрофилактика в комбустиологии (обзор литературы). Комбустиология (электронная версия). 4.

2. Иванько ОГ, Пацера МВ, Шальмин АС, Чернышова ЛИ. 2010. Использование пробиотических штаммов LACTOBACILLUS ACIDOPHILUS R0052 и LACTOBACILLUS RHAMNOSUS R 0011 при легочном туберкулезе у детей, осложненном антибиотико-ассоциированной CLOSTRIDIUM DIFFICILE кишечной инфекцией. Запорож мед журн. 3: 30—33.

3. Фисталь ЭЯ, Козинец ГП, Самойленко ГЕ, Носенко ВМ. 2007. Комбустиология детского возраста. Учебное пособие для врачей. Д, Вебер: 233.

4. Крутиков МГ. 2002. Проблемы инфекции у обожженных (обзор литературы). Комбустиология (электронная версия). 10.

5. Радутна ОА. 2011. Інфекційно-залежні механізми виникнення кишкових ускладнень під час антибіотикотерапії у дітей. Запорож мед журн. 13;4: 40—43.

6. Іванько ОГ, Пацера МВ, Радутна ОА. 2011. Клінічна характеристика та механізми формування уражень кишечника під час терапії антибіотиками у дітей. Проект робочої класифікації. ПАГ. 73;1: 33—39.

7. Чернишова ЛІ, Самарін ДВ, Крамарєв СО. 2006. Гострі кишкові інфекції у дітей. К: 163.

8. Dial S, Jayaraman D, Tompkins T, Menzies D. 2003. Evaluation of the effectiveness of the probiotic lacidofil in the prevention of antibioticassociated diarrhea: pilot study for a randomized controlled trial. Annual Scientific Exchange. Summary of probiotic Presentations & Poster abstracts, Institut Rosell-Lallemand Nutrition Group: 31—33.

9. Finegold SM, Mathisen GE. 1990. Metronidazol. Principlesand Practice of infectious diseases. 3rd ed. By Mandell, Douglas, Bennett. Edinburgh, London, Melbourne: 303—308.

10. Ivanko O, Radutna H. 2005. «Lacidofil®» in prevention antibiotic-associated diarrhea caused by Clostridium difficile infection. Annual Scientific Exchange. 2005, Sept. 7—8. Rome, Institut Rosell: 32—34.

11. Johnston BC, Supina AL, Vohra S. 2006. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ. 175;4: 377—383.

12. Kotowska M, Albrecht P, Szajewska H. 2005. Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial. Aliment. Pharmacol. Ther. 21;5: 583—590.

13. Lewis SJ, Heaton KW. 1997. Stool form scale as a useful guide to intestinal transit time. Scand J of Gastroenter. 32: 920—924.

14. Amsden GW, Mandell GL, Bennet JE (Eds.). 2000. Tables of antimicrobial agent pharmacology. In: Principles and Practice of Infectious Diseases. 5th ed. Philadelphia etc., Churchill Livingstone: 566—589.